Skip to main content
Log in

Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L.

  • Original Paper
  • Published:
Plant Foods for Human Nutrition Aims and scope Submit manuscript

Abstract

Nowadays, a growing body of evidence supports the view that plants offer an extraordinary opportunity to discover and develop new promising therapeutic strategies for many diseases, including cancer. Here we tested the anticancer action against Hepatocellular carcinoma (HCC) of extracts obtained from two plants harvested in Apulia, namely Brassica oleracea L. and Crithmum maritimum L. B. oleracea was grown in biodynamical agriculture without any agrochemical input, instead C. maritimum was collected on Apulian coasts and is still commonly eaten in Apulia. HCC, one of the most frequent tumors worldwide, is estimated to become the third leading cause of cancer-related deaths in Western Countries by 2030. The approved synthetic drugs for the treatment of HCC are currently inadequate in terms of therapeutic results and tolerability. Hence, aim of the present study was to test the anticancer action against HCC of extracts obtained from Brassica oleracea L. and Crithmum maritimum L. We preliminary prepared extracts from both plants using four solvents with different polarity: hexane, ethyl acetate, methanol and ethanol. Then, we tested the effect of the different fractions in inhibiting HCC cell growth. Finally, we characterized the mechanism of action of the most effective fraction. We found that ethyl acetate fractions from both plants were the most effective in inhibiting HCC growth. In particular, we demonstrated that these fractions effectively reduce HCC growth by exerting, on one hand, a cytostatic effect through their action on the cell cycle, and on the other hand by triggering apoptosis and necrosis. Our findings support the notion that ethyl acetate fractions from Apulian B. oleracea and C. maritimum can be in perspective considered as promising tools to expand the opportunities to identify new and not toxic anticancer therapeutic approaches for HCC. Further pharmacological investigations will shed light on how this could be effectively achieved.

Experimental workflow for the detection of the ethyl acetate extract of Brassica oleracea L. and Crithmum maritimum L. as an active fraction in inhibiting HCC cell growth

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ANOVA:

one-way analysis of variance

DMEM:

Dulbecco’s modified Eagle’s medium

DMSO:

dimethyl sulfoxide

EtOH:

ethanol

FBS:

fetal bovine serum

HCC:

hepatocellular carcinoma

HPLC:

high performance liquid chromatography

MetS:

metabolic syndrome

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

NAFLD:

non-alcoholic fatty liver disease

PBS:

phosphate buffered saline

SRB:

sulforhodamine B

References

  1. Butler MS, Newman DJ (2008) Mother nature’s gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery. Prog Drug Res 65(1):3–44

    Google Scholar 

  2. Newman DJ (2008) Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem 51(9):2589–2599. https://doi.org/10.1021/jm0704090

    Article  CAS  PubMed  Google Scholar 

  3. Coseri S (2009) Natural products and their analogues as efficient anticancer drugs. Mini-Rev Med Chem 9(5):560–571

    Article  CAS  PubMed  Google Scholar 

  4. de Lope CR, Tremosini S, Forner A, Reig M, Bruix J (2012) Management of HCC. J Hepatol 56(Suppl 1):S75–S87. https://doi.org/10.1016/S0168-8278(12)60009-9

    Article  CAS  PubMed  Google Scholar 

  5. Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet. https://doi.org/10.1016/S0140-6736(18)30010-2

    Article  Google Scholar 

  6. Kudo M (2018) Systemic Therapy for hepatocellular carcinoma: latest advances. Cancers (Basel) 10(11):E412. https://doi.org/10.3390/cancers10110412

    Article  CAS  Google Scholar 

  7. Waidmann O (2018) Recent Developments with immunotherapy for hepatocellular carcinoma. Expert Opin Biol Ther 18(8):905–910. https://doi.org/10.1080/14712598.2018.1499722

    Article  CAS  PubMed  Google Scholar 

  8. Wu Z, Lai L, Li M, Zhang L, Zhang W (2017) Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer: a case report. Medicine (Baltimore) 96(51):e9431. https://doi.org/10.1097/MD.0000000000009431

    Article  Google Scholar 

  9. Beecher CW (1994) Cancer preventive properties of varieties of Brassica oleracea: a review. Am J Clin Nutr 59(5 Suppl):1166S–1170S. https://doi.org/10.1093/ajcn/59.5.1166S

    Article  CAS  PubMed  Google Scholar 

  10. Murillo G, Mehta RG (2001) Cruciferous vegetables and cancer prevention. Nutr Cancer 41(1–2):17–28. https://doi.org/10.1080/01635581.2001.9680607

    Article  CAS  PubMed  Google Scholar 

  11. Talalay P, Fahey JW (2001) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 131(11 Suppl):3027S–3033S. https://doi.org/10.1093/jn/131.11.3027S

    Article  CAS  PubMed  Google Scholar 

  12. Novio S, Cartea ME, Soengas P, Freire-Garabal M, Nunez-Iglesias MJ (2016) Effects of brassicaceae isothiocyanates on prostate cancer. Molecules 21(5):E626. https://doi.org/10.3390/molecules21050626

    Article  CAS  PubMed  Google Scholar 

  13. Pappa G, Lichtenberg M, Iori R, Barillari J, Bartsch H, Gerhauser C (2006) Comparison of growth inhibition profiles and mechanisms of apoptosis induction in human colon cancer cell lines by isothiocyanates and indoles from brassicaceae. Mutat Res 599(1–2):76–87. https://doi.org/10.1016/j.mrfmmm.2006.01.007

    Article  CAS  PubMed  Google Scholar 

  14. Renna M (2018) Reviewing the prospects of sea fennel (Crithmum maritimum L.) as emerging vegetable crop. Plants (Basel) 7(4):E92. https://doi.org/10.3390/plants7040092

    Article  CAS  Google Scholar 

  15. Coiffard L, Piron-Frenet M, Amicel L (1993) Geographical variations of the constituents of the essential oil of Crithmum maritimum L., apiaceae. Int J Cosmet Sci 15(1):15–21. https://doi.org/10.1111/j.1467-2494.1993.tb00064.x

    Article  CAS  PubMed  Google Scholar 

  16. Meot-Duros L, Magne C (2009) Antioxidant activity and phenol content of Crithmum maritimum L. leaves. Plant Physiol Biochem 47(1):37–41. https://doi.org/10.1016/j.plaphy.2008.09.006

    Article  CAS  PubMed  Google Scholar 

  17. Ruberto G, Baratta MT, Deans SG, Dorman HJ (2000) Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med 66(8):687–693. https://doi.org/10.1055/s-2000-9773

    Article  CAS  PubMed  Google Scholar 

  18. Gerl R, Vaux DL (2005) Apoptosis in the development and treatment of cancer. Carcinogenesis 26(2):263–270. https://doi.org/10.1093/carcin/bgh283

    Article  CAS  PubMed  Google Scholar 

  19. Kang MR, Kim HM, Kang JS, Lee K, Lee SD, Hyun DH, In MJ, Park SK, Kim DC (2011) Lipid-soluble ginseng extract induces apoptosis and G0/G1 cell cycle arrest in NCI-H460 human lung cancer cells. Plant Foods Hum Nutr 66(2):101–106. https://doi.org/10.1007/s11130-011-0232-6

    Article  PubMed  Google Scholar 

  20. Kumar G, Gupta R, Sharan S, Roy P, Pandey DM (2019) Anticancer activity of plant veaves extract collected from a Tribal region of India. 3 Biotech 9(11):399. https://doi.org/10.1007/s13205-019-1927-x

    Article  PubMed  PubMed Central  Google Scholar 

  21. Jung S, Shin J, Oh J, Enkhtaivan G, Lee SW, Gopal J, Sydara K, Saini RK, Keum YS, Oh JW (2019) Cytotoxic and apoptotic potential of Phyllodium elegans extracts on human cancer cell lines. Bioengineered. https://doi.org/10.1080/21655979.2019.1682110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gordaliza M (2007) Natural products as leads to anticancer drugs. Clin Transl Oncol 9(12):767–776

    Article  CAS  PubMed  Google Scholar 

  23. Saklani A, Kutty SK (2008) Plant-derived compounds in clinical trials. Drug Discov Today 13(3–4):161–171. https://doi.org/10.1016/j.drudis.2007.10.010

    Article  CAS  PubMed  Google Scholar 

  24. Karna P, Chagani S, Gundala SR, Rida PC, Asif G, Sharma V, Gupta MV, Aneja R (2012) Benefits of whole ginger extract in prostate cancer. Br J Nutr 107(4):473–484. https://doi.org/10.1017/S0007114511003308

    Article  CAS  PubMed  Google Scholar 

  25. Liu RH (2003) Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. Am J Clin Nutr 78(3 Suppl):517S–520S. https://doi.org/10.1093/ajcn/78.3.517S

    Article  CAS  PubMed  Google Scholar 

  26. Thoppil RJ, Harlev E, Mandal A, Nevo E, Bishayee A (2013) Antitumor activities of extracts from selected desert plants against HepG2 human hepatocellular carcinoma cells. Pharm Biol 51(5):668–674. https://doi.org/10.3109/13880209.2012.749922

    Article  PubMed  Google Scholar 

  27. Ma JF, Wei PF, Guo C, Shi YP, Lv Y, Qiu LX, Wen LP (2018) The ethyl acetate extract of Gynura formosana Kitam. leaves inhibited cervical cancer cell proliferation via induction of autophagy. Biomed Res Int 2018:4780612. https://doi.org/10.1155/2018/4780612

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cao Z, Lin W, Huang Z, Chen X, Zhao J, Zheng L, Ye H, Liu Z, Liao L, Du J (2013) Ethyl acetate extraction from a Chinese herbal formula, Jiedu Xiaozheng Yin, inhibits the proliferation of hepatocellular carcinoma cells via induction of G0/G1 phase arrest in vivo and in vitro. Int J Oncol 42(1):202–210. https://doi.org/10.3892/ijo.2012.1703

    Article  PubMed  Google Scholar 

  29. Chen XZ, Cao ZY, Li JN, Hu HX, Zhang YQ, Huang YM, Liu ZZ, Hu D, Liao LM, Du J (2014) Ethyl acetate extract from Jiedu Xiaozheng Yin inhibits the proliferation of human hepatocellular carcinoma cells by suppressing polycomb gene product Bmi1 and Wnt/beta-catenin signaling. Oncol Rep 32(6):2710–2718. https://doi.org/10.3892/or.2014.3541

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Ms. Loredana Acquaro for her precious technical support and to Dr. Marco Troisi for his technical support with the high-performance liquid chromatographic analysis. We are also in debt with Mr. Vito Moretti, who kindly provided us with B. oleracea, which was harvested in his biodynamic agricultural farm “La Calamita Rosa” (Castellaneta, Taranto, Italy).

Funding

This work was supported by Agenzia Regionale Strategica per la Salute ed. il Sociale – ARESS Puglia – in accordance with the project “The Apulian Lifestyle” – Delibera di Giunta n. 556 (18/04/2017).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Mazzocca.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(PDF 3045 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gnocchi, D., Cesari, G., Calabrese, G.J. et al. Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L.. Plant Foods Hum Nutr 75, 33–40 (2020). https://doi.org/10.1007/s11130-019-00781-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11130-019-00781-3

Keywords

Navigation